Assessment of Postoperative Pain After Using Two Formulations of Calcium Hydroxide Intracanal Medication .

• Status: Recruiting
• Trial end date: 2022-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Calcium hydroxide is advocated as an intracanal medication for various purposes, including prevention of post-treatment symptoms. Calcium hydroxide has a pain-controlling effect at different times when compared to non-intracanal medication .

Aim:

The aim of the study to compare between postoperative pain after using two formulations of calcium hydroxide intracanal medication with and without iodoform .

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Suez Canal University
• Treatments: Calcium

Criteria

Inclusion Criteria:

• Single rooted teeth with and without radiographic evidence of apical periodontitis and a diagnosis of pulp necrosis confirmed by negative response to cold test and clinically by absence of blood .

• Clinical signs of apical periodontitis.

• Teeth with sufficient coronal tooth structure for adequate rubber dam isolation were selected .

• Patients who are over 18 years old .

Exclusion Criteria:

• Presence of open apices

• Presence of non-restorable teeth

• Presence of large carious lesions approaching the root.

• Presence of calcification or resorption .

• Patients who had received antibiotics during the last 3 months .

• Teeth with periodontal probing depth > 4 ml.

• Teeth with previous root canal treatment .

• Teeth with fluctuant facial swelling .

• Pregnant females.